Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TK1 | P04183 | 1/20 | 0.55 |
| ▸ | F2 | P00734 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8522569 | 1.00 | TDP1 (0.61) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL8522570 | 1.00 | TDP1 (0.61) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL11612353 | 0.92 | TDP1 (0.53) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL11570740 | 0.92 | TDP1 (0.53) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL11570739 | 0.92 | TDP1 (0.53) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL10540715 | 0.92 | TDP1 (0.53) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL11570806 | 0.92 | TDP1 (0.53) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL11570808 | 0.92 | TDP1 (0.53) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL9838229 | 0.92 | TDP1 (0.53) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL11571204 | 0.91 | TDP1 (0.52) | TDP1MAPK1HIF1ASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10011664-B2 | Functionalized nitrile rubbers and the production thereof | ARLANXEO DEUTSCHLAND GMBH (DE) | 2018-07-03 | — | — | US | claimed |
| US-20170190806-A1 | FUNCTIONALISED NITRILE RUBBERS AND THE PRODUCTION THEREOF | LANXESS DEUTSCHLAND GMBH (DE) | 2017-07-06 | — | — | US | claimed |
| EP-2670782-A1 | FUNCTIONALISED NITRILE RUBBERS AND THE PRODUCTION THEREOF | LANXESS Deutschland GmbH (DE) | 2013-12-11 | — | — | EP | claimed |
| EP-2484700-B1 | Functionalised nitrile rubbers and their manufacture | LANXESS DEUTSCHLAND GMBH (DE) | 2013-10-09 | — | — | EP | claimed |
| WO-2012104183-A1 | FUNCTIONALISED NITRILE RUBBERS AND THE PRODUCTION THEREOF | LANXESS DEUTSCHLAND GMBH (DE) | 2012-08-09 | — | — | WO | claimed |
| EP-2484700-A1 | Functionalised nitrile rubbers and their manufacture | LANXESS Deutschland GmbH (DE) | 2012-08-08 | — | — | EP | claimed |
| EP-4149912-B1 | PROCESS FOR PREPARING DIENE | FIRMENICH & CIE (CH) | 2025-04-30 | — | — | EP | disclosed |
| US-12103898-B2 | Process for preparing diene | FIRMENICH SA (CH) | 2024-10-01 | — | — | US | disclosed |
| US-20230265025-A1 | PROCESS FOR PREPARING DIENE | FIRMENICH SA (CH) | 2023-08-24 | — | — | US | disclosed |
| US-11713361-B2 | Hydrogenation catalyst compositions and their use for hydrogenation of nitrile rubber | ARLANXEO DEUTSCHLAND GMBH (DE) | 2023-08-01 | — | — | US | disclosed |
| US-11713361-B2 | Hydrogenation catalyst compositions and their use for hydrogenation of nitrile rubber | ARLANXEO DEUTSCHLAND GMBH (DE) | 2023-08-01 | — | — | US | disclosed |
| CN-115916732-A | Process for preparing dienes | 弗门尼舍有限公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-4149912-A1 | PROCESS FOR PREPARING DIENE | Firmenich SA (CH) | 2023-03-22 | — | — | EP | disclosed |
| WO-2013056461-A1 | CATALYST COMPOSITIONS AND THEIR USE FOR HYDROGENATION OF NITRILE RUBBER | LANXESS DEUTSCHLAND GMBH (DE) | 2013-04-25 | — | — | WO | disclosed |
| WO-2013056400-A1 | CATALYST COMPOSITIONS AND THEIR USE FOR HYDROGENATION OF NITRILE RUBBER | LANXESS DEUTSCHLAND GMBH (DE) | 2013-04-25 | — | — | WO | disclosed |
| WO-2013057289-A2 | CATALYST COMPOSITIONS AND THEIR USE FOR HYDROGENATION OF NITRILE RUBBER | LANXESS DEUTSCHLAND GMBH (DE) | 2013-04-25 | — | — | WO | disclosed |
| WO-2013057295-A2 | CATALYST COMPOSITIONS AND THEIR USE FOR HYDROGENATION OF NITRILE RUBBER | LANXESS DEUTSCHLAND GMBH (DE) | 2013-04-25 | — | — | WO | disclosed |
| EP-2484700-A1 | Functionalised nitrile rubbers and their manufacture | LANXESS Deutschland GmbH (DE) | 2012-08-08 | — | — | EP | disclosed |
| EP-2484700-A1 | Functionalised nitrile rubbers and their manufacture | LANXESS Deutschland GmbH (DE) | 2012-08-08 | — | — | EP | disclosed |
| WO-2009030733-A1 | METHOD FOR THE SYNTHESIS OF 4-ALKOXY-, 4-HYDROXY- AND 4-ARYLOXY-SUBSTITUTED TETRAHYDRO-FURO[3,4-B]FURAN-2(3H)-ONE COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2009-03-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265025-A1 | PROCESS FOR PREPARING DIENE | FDFT1, SQLE, DHPS | TDP1 3470/4885MAPK1 2434/4885HIF1A 1813/4885 |
| US-12103898-B2 | Process for preparing diene | FDFT1, SQLE, DHPS | TDP1 3470/4885MAPK1 2434/4885HIF1A 1813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.